Free Trial

Scotts Miracle-Gro (SMG) Financials

Scotts Miracle-Gro logo
$51.51 +0.32 (+0.63%)
As of 04/14/2025 03:58 PM Eastern
Annual Income Statements for Scotts Miracle-Gro

Annual Income Statements for Scotts Miracle-Gro

This table shows Scotts Miracle-Gro's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
160 315 218 64 461 387 513 -438 -380 -35
Consolidated Net Income / (Loss)
159 315 219 64 460 389 513 -438 -380 -35
Net Income / (Loss) Continuing Operations
129 246 198 128 437 387 517 -438 -380 -35
Total Pre-Tax Income
205 384 315 116 582 511 677 -558 -453 -24
Total Operating Income
254 448 433 199 410 585 723 -434 -174 209
Total Gross Profit
811 900 973 865 1,020 1,347 1,469 873 657 851
Total Revenue
2,371 2,506 2,642 2,663 3,156 4,132 4,925 3,924 3,551 3,553
Operating Revenue
2,371 2,506 2,642 2,663 3,156 4,132 4,925 3,924 3,551 3,553
Total Cost of Revenue
1,560 1,606 1,670 1,799 2,136 2,785 3,456 3,051 2,894 2,702
Operating Cost of Revenue
1,557 1,600 1,670 1,778 2,131 2,769 3,431 2,891 2,708 2,619
Other Cost of Revenue
3.00 5.90 0.00 21 5.90 16 25 160 186 84
Total Operating Expenses
557 453 539 666 610 762 746 1,307 832 642
Selling, General & Admin Expense
489 518 551 540 601 758 744 613 551 559
Other Operating Expenses / (Income)
-2.20 -14 -17 -6.70 1.30 3.20 -1.80 0.80 -0.10 20
Restructuring Charge
70 -52 4.90 132 7.40 0.80 4.30 693 281 63
Total Other Income / (Expense), net
-49 -64 -119 -83 172 -75 -46 -124 -279 -232
Interest Expense
49 72 76 86 102 95 79 118 178 159
Interest & Investment Income
0.00 7.80 -29 4.90 3.30 0.00 14 -13 -101 -68
Other Income / (Expense), net
0.00 0.00 -13 -1.70 271 20 19 6.90 0.30 -5.50
Income Tax Expense
76 138 117 -12 145 124 160 -121 -73 11
Basic Earnings per Share
$2.62 $5.16 $3.68 $1.13 $8.30 $6.96 $9.20 ($7.88) ($6.79) ($0.61)
Weighted Average Basic Shares Outstanding
61.10M 61.10M 59.40M 56.20M 55.82M 55.74M 55.16M 55.46M 56.55M 57.41M
Diluted Earnings per Share
$2.57 $5.09 $3.63 $1.12 $8.18 $6.81 $8.96 ($7.88) ($6.79) ($0.61)
Weighted Average Diluted Shares Outstanding
61.10M 61.10M 59.40M 56.20M 55.82M 55.74M 55.16M 55.46M 56.55M 57.41M
Weighted Average Basic & Diluted Shares Outstanding
61.10M 61.10M 59.40M 56.20M 55.82M 55.74M 55.16M 55.46M 56.55M 57.41M
Cash Dividends to Common per Share
$1.82 $1.91 $2.03 $2.14 $2.23 $7.36 $2.52 $2.64 $2.64 $2.64

Quarterly Income Statements for Scotts Miracle-Gro

This table shows Scotts Miracle-Gro's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Net Income / (Loss) Attributable to Common Shareholders
-444 -220 -65 109 44 -469 -81 158 132 -244 -70
Consolidated Net Income / (Loss)
-444 -220 -65 109 44 -469 -81 158 132 -244 -70
Net Income / (Loss) Continuing Operations
-444 -220 -65 109 44 -469 -81 158 132 -244 -70
Total Pre-Tax Income
-577 -272 -94 150 52 -561 -114 220 183 -312 -96
Total Operating Income
-563 -224 -42 206 77 -416 -47 272 200 -216 -51
Total Gross Profit
237 -71 96 413 206 -57 62 464 354 -30 95
Total Revenue
1,186 494 527 1,532 1,119 375 410 1,525 1,202 415 417
Operating Revenue
1,186 494 527 1,532 1,119 375 410 1,525 1,202 415 417
Total Cost of Revenue
950 564 431 1,119 913 432 348 1,062 848 444 322
Operating Cost of Revenue
884 475 421 1,000 880 408 354 987 851 427 317
Other Cost of Revenue
66 89 10 119 33 24 -5.80 75 -2.50 17 5.10
Total Operating Expenses
799 153 138 207 129 359 110 192 154 187 146
Selling, General & Admin Expense
136 118 129 186 129 108 115 179 148 118 125
Other Operating Expenses / (Income)
4.90 2.00 0.50 -1.60 -1.60 2.60 1.80 11 6.90 0.40 4.50
Restructuring Charge
658 33 8.50 22 1.70 249 -7.10 2.10 -0.80 69 17
Total Other Income / (Expense), net
-14 -48 -53 -56 -25 -145 -67 -52 -17 -96 -45
Interest Expense
31 35 43 48 47 40 43 44 39 33 34
Interest & Investment Income
15 -14 -11 -7.30 22 -105 -23 -7.00 23 -62 -9.90
Other Income / (Expense), net
1.70 1.50 1.60 -0.80 -0.40 -0.10 -1.60 -1.20 -1.30 -1.40 -1.30
Income Tax Expense
-133 -52 -30 40 8.30 -92 -34 62 51 -68 -26
Basic Earnings per Share
($8.01) ($3.95) ($1.17) $1.95 $0.78 ($8.35) ($1.42) $2.77 $2.33 ($4.29) ($1.21)
Weighted Average Basic Shares Outstanding
55.40M 55.46M 55.50M 56M 56.20M 56.55M 56.70M 56.80M 56.80M 57.41M 57.30M
Diluted Earnings per Share
($8.01) ($3.91) ($1.17) $1.94 $0.77 ($8.33) ($1.42) $2.74 $2.28 ($4.21) ($1.21)
Weighted Average Diluted Shares Outstanding
55.40M 55.46M 55.50M 56.50M 56.60M 56.55M 56.70M 57.40M 58M 57.41M 57.30M
Weighted Average Basic & Diluted Shares Outstanding
55.41M 55.46M 55.96M 56.07M 56.16M 56.55M 56.69M 56.80M 56.82M 57.41M 57.47M
Cash Dividends to Common per Share
$0.66 - $0.66 $0.66 $0.66 - $0.66 - $0.66 - $0.66

Annual Cash Flow Statements for Scotts Miracle-Gro

This table details how cash moves in and out of Scotts Miracle-Gro's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-18 -21 70 -87 -15 -2.20 228 -157 -55 40
Net Cash From Operating Activities
247 244 363 343 227 558 272 -129 531 668
Net Cash From Continuing Operating Activities
247 244 363 343 227 558 272 -129 531 668
Net Income / (Loss) Continuing Operations
159 315 219 64 460 389 513 -438 -380 -35
Consolidated Net Income / (Loss)
159 315 219 64 460 389 513 -438 -380 -35
Depreciation Expense
51 54 55 53 56 62 63 68 67 65
Amortization Expense
18 20 25 30 33 33 31 37 25 16
Non-Cash Adjustments To Reconcile Net Income
18 -114 24 169 -224 73 38 714 459 233
Changes in Operating Assets and Liabilities, net
1.70 -30 40 27 -99 1.70 -374 -511 360 389
Net Cash From Investing Activities
-536 -134 22 -581 255 47 -539 -283 -66 -100
Net Cash From Continuing Investing Activities
-536 -134 22 -581 255 47 -539 -283 -66 -100
Purchase of Property, Plant & Equipment
-62 -58 -70 -68 -42 -63 -107 -114 -93 -84
Acquisitions
-480 -183 -122 -528 -6.60 0.00 -128 -237 0.00 -21
Purchase of Investments
0.00 - - - 0.00 -3.40 -295 -25 0.00 0.00
Sale of Property, Plant & Equipment
5.50 2.40 5.70 5.10 2.10 116 0.20 63 2.50 2.40
Other Investing Activities, net
0.00 -90 -30 11 7.00 -2.90 -8.70 29 25 2.60
Net Cash From Financing Activities
279 -129 -317 151 -497 -607 494 255 -520 -528
Net Cash From Continuing Financing Activities
279 -129 -317 151 -497 -607 494 255 -520 -528
Repayment of Debt
-1,460 -2,364 -1,651 -2,328 -1,447 -1,833 -1,375 -2,941 -1,700 -1,024
Repurchase of Common Equity
-15 -137 -255 -398 -3.10 -53 -129 -258 -9.30 -5.10
Payment of Dividends
-111 -117 -128 -120 -125 -411 -143 -166 -149 -151
Issuance of Debt
1,836 2,469 1,449 2,987 1,056 1,673 2,143 3,617 1,336 649
Other Financing Activities, net
29 21 269 11 21 18 -2.30 3.30 2.30 3.80
Other Net Changes in Cash
- - 1.60 - - 0.00 0.60 - -0.10 0.50

Quarterly Cash Flow Statements for Scotts Miracle-Gro

This table details how cash moves in and out of Scotts Miracle-Gro's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Net Change in Cash & Equivalents
11 59 -61 -0.60 2.40 4.50 -22 55 215 -208 -62
Net Cash From Operating Activities
463 551 -432 -135 563 535 -343 304 588 119 -445
Net Cash From Continuing Operating Activities
463 551 -432 -135 563 535 -343 304 588 119 -445
Net Income / (Loss) Continuing Operations
-444 -220 -65 109 44 -468 -81 158 132 -244 -70
Consolidated Net Income / (Loss)
-444 -220 -65 109 44 -468 -81 158 132 -244 -70
Depreciation Expense
18 18 18 16 16 18 16 16 17 16 16
Amortization Expense
9.20 8.60 7.70 6.40 6.70 4.40 4.00 3.90 3.90 3.90 3.10
Non-Cash Adjustments To Reconcile Net Income
628 45 36 85 -22 359 39 41 -1.10 154 38
Changes in Operating Assets and Liabilities, net
252 699 -428 -352 519 622 -322 86 437 188 -433
Net Cash From Investing Activities
-79 51 -36 15 -24 -21 -53 -18 -8.90 -20 -23
Net Cash From Continuing Investing Activities
-79 51 -36 15 -24 -21 -53 -18 -8.90 -20 -23
Purchase of Property, Plant & Equipment
-33 -15 -30 -22 -22 -19 -38 -16 -13 -17 -29
Acquisitions
-35 - - - - - -21 - - - 0.00
Other Investing Activities, net
13 12 -6.40 0.60 -2.00 32 6.10 -1.60 4.30 -6.20 6.00
Net Cash From Financing Activities
-373 -543 406 119 -536 -509 374 -231 -364 -307 408
Net Cash From Continuing Financing Activities
-373 -543 406 119 -536 -509 374 -231 -364 -307 408
Repayment of Debt
-2,167 -684 -203 -385 -600 -512 -31 -266 -456 -271 -63
Repurchase of Common Equity
-1.30 -0.20 -0.80 -5.60 -2.90 - -3.10 -1.80 -0.10 -0.10 -16
Payment of Dividends
-36 -37 -37 -38 -37 -37 -37 -39 -38 -38 -39
Issuance of Debt
1,830 177 646 548 103 40 445 74 129 - 525
Other Financing Activities, net
0.80 0.70 0.60 0.60 0.50 0.60 0.50 1.20 0.70 1.40 0.70
Effect of Exchange Rate Changes
-0.20 -0.30 0.20 0.20 0.10 - - -0.20 -0.40 - -0.90

Annual Balance Sheets for Scotts Miracle-Gro

This table presents Scotts Miracle-Gro's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
2,527 2,756 2,747 3,055 3,029 3,381 4,800 4,297 3,414 2,872
Total Current Assets
1,119 1,033 882 886 1,042 1,217 2,024 1,982 1,398 980
Cash & Equivalents
71 29 121 34 19 17 244 87 32 72
Accounts Receivable
158 127 198 226 224 475 483 379 304 177
Inventories, net
396 395 408 481 540 622 1,127 1,344 880 588
Prepaid Expenses
121 52 67 60 174 81 170 173 181 145
Plant, Property, & Equipment, net
444 445 468 531 546 0.00 622 606 610 610
Total Noncurrent Assets
964 1,278 1,398 1,638 1,441 2,164 2,154 1,709 1,406 1,282
Long-Term Investments
0.00 101 31 36 - 0.00 207 194 92 45
Goodwill
284 372 442 543 539 544 605 254 244 244
Intangible Assets
655 690 749 857 708 679 710 580 437 419
Other Noncurrent Operating Assets
25 115 176 202 195 941 632 681 633 574
Total Liabilities & Shareholders' Equity
2,527 2,756 2,747 3,055 3,029 3,381 4,800 4,297 3,414 2,872
Total Liabilities
1,894 2,022 2,085 2,695 2,306 2,678 3,787 4,149 3,681 3,263
Total Current Liabilities
619 707 545 613 621 950 1,140 964 774 750
Short-Term Debt
133 185 143 133 128 66 58 144 52 53
Accounts Payable
193 131 153 151 214 391 609 423 271 255
Other Current Liabilities
251 178 248 330 278 493 473 397 450 443
Total Noncurrent Liabilities
1,276 1,314 1,541 2,082 1,685 1,727 2,646 3,185 2,907 2,512
Long-Term Debt
1,025 1,031 1,258 1,884 1,524 1,455 2,237 2,826 2,557 2,174
Other Noncurrent Operating Liabilities
251 284 283 198 162 272 410 359 350 338
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
633 734 662 360 723 703 1,013 148 -267 -391
Total Preferred & Common Equity
621 715 649 355 719 697 1,013 148 -267 -391
Total Common Equity
621 715 649 355 719 697 1,013 148 -267 -391
Common Stock
400 402 408 420 442 483 477 364 353 362
Retained Earnings
684 882 978 920 1,275 1,236 1,605 1,020 491 304
Treasury Stock
-357 -451 -668 -940 -904 -922 -1,002 -1,092 -999 -949
Accumulated Other Comprehensive Income / (Loss)
-107 -117 -69 -46 -94 -99 -66 -145 -113 -107

Quarterly Balance Sheets for Scotts Miracle-Gro

This table presents Scotts Miracle-Gro's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Total Assets
4,994 4,534 4,988 4,454 3,716 3,924 3,489 3,170
Total Current Assets
2,589 2,299 2,842 2,251 1,681 1,935 1,538 1,285
Cash & Equivalents
28 26 25 27 10 65 280 9.80
Accounts Receivable
953 490 1,458 1,160 288 877 505 214
Inventories, net
1,408 1,526 1,128 885 1,170 824 607 910
Prepaid Expenses
201 258 232 179 214 169 147 152
Plant, Property, & Equipment, net
625 593 589 590 610 608 599 607
Total Noncurrent Assets
1,780 1,642 1,557 1,613 1,424 1,381 1,352 1,278
Long-Term Investments
208 182 174 197 91 84 107 46
Goodwill
255 254 254 255 244 244 244 244
Intangible Assets
627 576 566 560 433 429 425 415
Other Noncurrent Operating Assets
690 630 563 602 656 624 576 573
Total Liabilities & Shareholders' Equity
4,994 4,534 4,988 4,454 3,716 3,924 3,489 3,170
Total Liabilities
4,576 4,475 4,851 4,320 4,102 4,175 3,636 3,650
Total Current Liabilities
1,072 932 1,373 1,329 764 1,060 854 684
Short-Term Debt
322 217 435 451 55 58 53 55
Accounts Payable
291 367 416 366 333 440 317 309
Other Current Liabilities
459 348 522 513 377 562 485 320
Total Noncurrent Liabilities
3,504 3,543 3,478 2,991 3,337 3,115 2,781 2,966
Long-Term Debt
3,156 3,190 3,138 2,629 2,969 2,761 2,436 2,637
Other Noncurrent Operating Liabilities
348 353 340 362 368 354 345 329
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
418 60 138 135 -385 -251 -146 -480
Total Preferred & Common Equity
418 60 138 135 -385 -251 -146 -480
Total Common Equity
418 60 138 135 -385 -251 -146 -480
Common Stock
362 368 374 351 350 354 361 349
Retained Earnings
1,277 918 990 997 372 492 586 196
Treasury Stock
-1,096 -1,057 -1,040 -1,032 -986 -978 -976 -920
Accumulated Other Comprehensive Income / (Loss)
-125 -169 -187 -181 -122 -119 -117 -105

Annual Metrics and Ratios for Scotts Miracle-Gro

This table displays calculated financial ratios and metrics derived from Scotts Miracle-Gro's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-8.04% 5.70% 5.42% 0.81% 18.50% 30.91% 19.20% -20.32% -9.50% 0.04%
EBITDA Growth
-7.27% 61.43% -4.03% -43.89% 174.20% -9.02% 19.34% -138.53% 74.65% 447.92%
EBIT Growth
-10.54% 76.36% -6.17% -53.05% 244.88% -11.00% 22.52% -157.59% 59.24% 216.77%
NOPAT Growth
-12.88% 80.17% -4.93% -19.63% 40.21% 44.18% 24.57% -155.00% 59.82% 219.72%
Net Income Growth
-4.51% 98.36% -30.50% -70.89% 622.45% -15.56% 32.12% -185.22% 13.12% 90.82%
EPS Growth
-3.02% 98.05% -28.68% -69.15% 630.36% -16.75% 31.57% -187.95% 13.83% 91.02%
Operating Cash Flow Growth
2.49% -1.17% 48.85% -5.70% -33.78% 146.03% -51.34% -147.51% 511.63% 25.71%
Free Cash Flow Firm Growth
-265.76% 142.28% 176.12% -226.11% 246.80% 129.71% -116.32% -194.93% 274.54% 29.87%
Invested Capital Growth
22.06% 15.36% 7.53% 20.66% 2.17% -6.29% 29.39% -0.67% -21.81% -22.50%
Revenue Q/Q Growth
-8.47% 4.18% 13.02% 2.20% 2.06% 10.50% -3.00% -5.86% -3.24% 1.14%
EBITDA Q/Q Growth
-4.86% 4.64% 0.46% -26.83% 13.75% 12.41% -6.72% -133.43% -170.10% 225.20%
EBIT Q/Q Growth
-6.83% 5.27% 0.29% -34.79% 15.90% 13.91% -7.29% -77.59% -988.27% 4,319.57%
NOPAT Q/Q Growth
-9.00% 6.45% 1.11% -28.35% 31.46% 12.09% -6.12% -75.57% -1,085.31% 2,272.73%
Net Income Q/Q Growth
-5.37% -0.73% -2.89% -64.05% 23.91% 19.09% -9.21% -64.91% -188.61% 86.55%
EPS Q/Q Growth
-4.10% -1.17% -3.46% -64.44% 23.19% 19.26% -9.22% -63.83% -186.50% 87.10%
Operating Cash Flow Q/Q Growth
6.98% 25.90% -0.36% 27.70% -15.44% 60.81% -11.97% 35.82% -2.80% -38.44%
Free Cash Flow Firm Q/Q Growth
-208.63% 112.76% -53.24% 43.67% -12.89% 43.22% -140.04% 64.74% -27.09% -37.96%
Invested Capital Q/Q Growth
2.54% -17.99% -10.67% -16.36% -12.60% -17.56% -5.57% -22.46% -25.81% -12.11%
Profitability Metrics
- - - - - - - - - -
Gross Margin
34.20% 35.92% 36.81% 32.46% 32.31% 32.60% 29.83% 22.24% 18.51% 23.94%
EBITDA Margin
13.61% 20.79% 18.93% 10.54% 24.38% 16.94% 16.96% -8.20% -2.30% 7.99%
Operating Margin
10.70% 17.86% 16.40% 7.47% 12.98% 14.16% 14.68% -11.06% -4.91% 5.88%
EBIT Margin
10.70% 17.86% 15.90% 7.40% 21.55% 14.65% 15.06% -10.88% -4.90% 5.72%
Profit (Net Income) Margin
6.69% 12.56% 8.28% 2.39% 14.58% 9.41% 10.42% -11.15% -10.70% -0.98%
Tax Burden Percent
77.41% 82.04% 69.48% 55.06% 79.13% 76.11% 75.82% 78.39% 83.85% 147.88%
Interest Burden Percent
80.77% 85.72% 74.98% 58.67% 85.52% 84.35% 91.30% 130.67% 260.37% -11.61%
Effective Tax Rate
37.22% 35.86% 37.03% -10.29% 24.91% 24.23% 23.60% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
11.37% 17.30% 14.80% 10.40% 13.19% 19.43% 21.81% -10.67% -4.83% 7.42%
ROIC Less NNEP Spread (ROIC-NNEP)
11.29% 20.15% 10.08% 0.66% 21.72% 15.94% 19.49% -16.57% -14.80% -0.46%
Return on Net Nonoperating Assets (RNNOA)
15.07% 28.74% 16.55% 2.07% 71.81% 35.07% 38.02% -64.70% 640.45% 3.19%
Return on Equity (ROE)
26.44% 46.04% 31.35% 12.47% 85.00% 54.50% 59.83% -75.37% 635.62% 10.61%
Cash Return on Invested Capital (CROIC)
-8.50% 3.04% 7.54% -8.32% 11.05% 25.93% -3.81% -10.00% 19.66% 32.78%
Operating Return on Assets (OROA)
11.07% 16.94% 15.27% 6.80% 22.36% 18.89% 18.13% -9.39% -4.52% 6.47%
Return on Assets (ROA)
6.92% 11.92% 7.95% 2.20% 15.13% 12.13% 12.55% -9.62% -9.86% -1.11%
Return on Common Equity (ROCE)
25.87% 44.98% 30.63% 12.26% 84.26% 54.11% 59.63% -75.37% 635.62% 10.61%
Return on Equity Simple (ROE_SIMPLE)
25.57% 44.02% 33.72% 17.96% 64.03% 55.74% 50.67% -296.21% 142.20% 8.94%
Net Operating Profit after Tax (NOPAT)
159 287 273 219 308 443 552 -304 -122 146
NOPAT Margin
6.72% 11.46% 10.33% 8.24% 9.75% 10.73% 11.22% -7.74% -3.44% 4.11%
Net Nonoperating Expense Percent (NNEP)
0.08% -2.84% 4.72% 9.74% -8.53% 3.49% 2.33% 5.90% 9.97% 7.88%
Cost of Revenue to Revenue
65.80% 64.08% 63.19% 67.54% 67.69% 67.40% 70.17% 77.76% 81.49% 76.06%
SG&A Expenses to Revenue
20.61% 20.67% 20.85% 20.28% 19.05% 18.34% 15.10% 15.62% 15.52% 15.73%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.49% 18.06% 20.41% 24.99% 19.33% 18.44% 15.15% 33.30% 23.42% 18.06%
Earnings before Interest and Taxes (EBIT)
254 448 420 197 680 605 742 -427 -174 203
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
323 521 500 281 769 700 835 -322 -82 284
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
4.62 5.58 7.09 10.20 6.69 10.91 7.28 14.59 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.21 1.59 1.74 1.36 1.52 1.84 1.50 0.55 0.78 1.37
Price to Earnings (P/E)
17.95 12.66 21.06 56.78 10.43 19.63 14.40 0.00 0.00 0.00
Dividend Yield
3.89% 2.90% 2.58% 3.28% 2.57% 1.73% 1.91% 6.79% 5.38% 3.07%
Earnings Yield
5.57% 7.90% 4.75% 1.76% 9.58% 5.10% 6.94% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.57 2.87 3.07 2.41 2.74 4.13 3.23 1.71 2.36 4.07
Enterprise Value to Revenue (EV/Rev)
1.67 2.03 2.22 2.09 2.04 2.21 1.87 1.23 1.48 1.97
Enterprise Value to EBITDA (EV/EBITDA)
12.29 9.78 11.72 19.84 8.38 13.02 11.04 0.00 0.00 24.64
Enterprise Value to EBIT (EV/EBIT)
15.63 11.39 13.95 28.24 9.48 15.06 12.44 0.00 0.00 34.40
Enterprise Value to NOPAT (EV/NOPAT)
24.90 17.75 21.47 25.38 20.95 20.55 16.70 0.00 0.00 47.85
Enterprise Value to Operating Cash Flow (EV/OCF)
16.07 20.89 16.13 16.26 28.41 16.33 33.97 0.00 9.87 10.48
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 101.14 42.12 0.00 25.02 15.40 0.00 0.00 10.55 10.84
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.83 1.66 2.12 5.61 2.28 2.16 2.26 20.11 -9.76 -5.70
Long-Term Debt to Equity
1.62 1.40 1.90 5.24 2.11 2.07 2.21 19.13 -9.57 -5.57
Financial Leverage
1.34 1.43 1.64 3.13 3.31 2.20 1.95 3.90 -43.28 -6.99
Leverage Ratio
3.82 3.86 3.94 5.68 5.62 4.49 4.77 7.84 -64.47 -9.55
Compound Leverage Factor
3.09 3.31 2.96 3.33 4.80 3.79 4.35 10.24 -167.86 1.11
Debt to Total Capital
64.65% 62.35% 67.92% 84.87% 69.55% 68.40% 69.37% 95.26% 111.41% 121.27%
Short-Term Debt to Total Capital
7.40% 9.49% 6.94% 5.58% 5.39% 2.99% 1.75% 4.63% 2.23% 2.86%
Long-Term Debt to Total Capital
57.24% 52.86% 60.99% 79.28% 64.15% 65.42% 67.62% 90.64% 109.18% 118.41%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.69% 0.98% 0.63% 0.21% 0.19% 0.26% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
34.66% 36.67% 31.45% 14.92% 30.26% 31.34% 30.63% 4.74% -11.41% -21.27%
Debt to EBITDA
3.59 2.33 2.80 7.19 2.15 2.17 2.75 -9.23 -31.98 7.84
Net Debt to EBITDA
3.36 2.08 2.50 6.94 2.12 2.15 2.21 -8.36 -30.46 7.43
Long-Term Debt to EBITDA
3.18 1.98 2.52 6.71 1.98 2.08 2.68 -8.78 -31.34 7.66
Debt to NOPAT
7.27 4.24 5.13 9.19 5.37 3.43 4.15 -9.78 -21.38 15.24
Net Debt to NOPAT
6.82 3.78 4.58 8.87 5.31 3.39 3.34 -8.85 -20.36 14.44
Long-Term Debt to NOPAT
6.43 3.59 4.61 8.59 4.95 3.28 4.05 -9.30 -20.95 14.88
Altman Z-Score
2.80 3.22 3.43 2.42 3.79 4.12 3.39 1.51 1.74 2.61
Noncontrolling Interest Sharing Ratio
2.16% 2.30% 2.29% 1.75% 0.88% 0.72% 0.33% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.81 1.46 1.62 1.45 1.68 1.28 1.77 2.06 1.81 1.31
Quick Ratio
0.62 0.47 0.75 0.56 0.53 0.54 0.64 0.48 0.43 0.33
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-119 50 139 -175 258 592 -97 -285 497 645
Operating Cash Flow to CapEx
439.32% 436.49% 568.39% 542.79% 562.78% 0.00% 254.45% -256.97% 588.04% 818.01%
Free Cash Flow to Firm to Interest Expense
-2.44 0.70 1.83 -2.03 2.53 6.25 -1.22 -2.41 2.79 4.06
Operating Cash Flow to Interest Expense
5.06 3.40 4.77 3.96 2.23 5.89 3.44 -1.09 2.98 4.20
Operating Cash Flow Less CapEx to Interest Expense
3.91 2.62 3.93 3.23 1.83 6.45 2.09 -1.52 2.47 3.69
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.03 0.95 0.96 0.92 1.04 1.29 1.20 0.86 0.92 1.13
Accounts Receivable Turnover
12.42 17.61 16.27 12.57 14.03 11.83 10.28 9.10 10.40 14.77
Inventory Turnover
4.00 4.06 4.16 4.05 4.18 4.79 3.95 2.47 2.60 3.68
Fixed Asset Turnover
5.38 5.64 5.79 5.33 5.86 0.00 0.00 6.39 5.84 5.83
Accounts Payable Turnover
8.08 9.90 11.74 11.85 11.72 9.20 6.91 5.91 8.34 10.28
Days Sales Outstanding (DSO)
29.38 20.73 22.43 29.03 26.02 30.86 35.51 40.10 35.10 24.71
Days Inventory Outstanding (DIO)
91.34 89.84 87.69 90.18 87.28 76.17 92.33 147.74 140.24 99.13
Days Payable Outstanding (DPO)
45.20 36.85 31.08 30.80 31.15 39.66 52.83 61.73 43.75 35.52
Cash Conversion Cycle (CCC)
75.52 73.71 79.04 88.42 82.14 67.37 75.01 126.12 131.58 88.32
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
1,541 1,777 1,911 2,306 2,356 2,208 2,857 2,838 2,219 1,719
Invested Capital Turnover
1.69 1.51 1.43 1.26 1.35 1.81 1.94 1.38 1.40 1.80
Increase / (Decrease) in Invested Capital
279 237 134 395 50 -148 649 -19 -619 -499
Enterprise Value (EV)
3,967 5,096 5,859 5,568 6,444 9,114 9,224 4,846 5,242 6,994
Market Capitalization
2,869 3,991 4,597 3,617 4,807 7,603 7,380 2,156 2,756 4,884
Book Value per Share
$10.13 $11.80 $11.11 $6.40 $12.95 $12.50 $18.16 $2.67 ($4.76) ($6.87)
Tangible Book Value per Share
($5.19) ($5.72) ($9.27) ($18.86) ($9.51) ($9.43) ($5.40) ($12.39) ($16.88) ($18.54)
Total Capital
1,791 1,950 2,063 2,376 2,375 2,224 3,308 3,118 2,342 1,836
Total Debt
1,158 1,216 1,401 2,016 1,652 1,522 2,295 2,971 2,610 2,227
Total Long-Term Debt
1,025 1,031 1,258 1,884 1,524 1,455 2,237 2,826 2,557 2,174
Net Debt
1,086 1,086 1,250 1,946 1,633 1,505 1,843 2,690 2,486 2,110
Capital Expenditures (CapEx)
56 56 64 63 40 -53 107 50 90 82
Debt-free, Cash-free Net Working Capital (DFCFNWC)
562 482 360 372 531 316 697 1,076 645 211
Debt-free Net Working Capital (DFNWC)
633 511 480 406 549 333 941 1,162 676 283
Net Working Capital (NWC)
501 326 337 273 421 266 884 1,018 624 230
Net Nonoperating Expense (NNE)
0.64 -28 54 156 -153 55 39 134 258 181
Net Nonoperating Obligations (NNO)
908 1,043 1,250 1,946 1,633 1,505 1,843 2,690 2,486 2,110
Total Depreciation and Amortization (D&A)
69 74 80 83 89 95 94 105 93 81
Debt-free, Cash-free Net Working Capital to Revenue
23.69% 19.24% 13.62% 13.96% 16.81% 7.65% 14.16% 27.41% 18.15% 5.94%
Debt-free Net Working Capital to Revenue
26.70% 20.38% 18.18% 15.23% 17.40% 8.05% 19.11% 29.62% 19.05% 7.96%
Net Working Capital to Revenue
21.11% 13.00% 12.76% 10.25% 13.35% 6.44% 17.94% 25.94% 17.57% 6.48%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$2.62 $5.16 $3.68 $1.13 $8.30 $6.96 $9.20 ($7.88) ($6.79) ($0.61)
Adjusted Weighted Average Basic Shares Outstanding
61.51M 60.09M 57.53M 55.33M 55.82M 55.74M 55.16M 55.46M 56.55M 57.41M
Adjusted Diluted Earnings per Share
$2.57 $5.09 $3.63 $1.12 $8.18 $6.81 $8.96 ($7.88) ($6.79) ($0.61)
Adjusted Weighted Average Diluted Shares Outstanding
61.51M 60.09M 57.53M 55.33M 55.82M 55.74M 55.16M 55.46M 56.55M 57.41M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
61.51M 60.09M 57.53M 55.33M 55.82M 55.74M 55.16M 55.46M 56.55M 57.41M
Normalized Net Operating Profit after Tax (NOPAT)
204 254 276 232 313 444 556 181 74 190
Normalized NOPAT Margin
8.58% 10.14% 10.45% 8.70% 9.92% 10.75% 11.28% 4.62% 2.09% 5.35%
Pre Tax Income Margin
8.65% 15.31% 11.92% 4.34% 18.43% 12.36% 13.75% -14.22% -12.76% -0.66%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
5.20 6.24 5.52 2.28 6.68 6.39 9.40 -3.62 -0.98 1.28
NOPAT to Interest Expense
3.27 4.00 3.59 2.54 3.02 4.68 7.00 -2.57 -0.69 0.92
EBIT Less CapEx to Interest Expense
4.05 5.46 4.68 1.55 6.28 6.95 8.05 -4.04 -1.48 0.77
NOPAT Less CapEx to Interest Expense
2.11 3.22 2.75 1.81 2.63 5.24 5.65 -3.00 -1.19 0.41
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
70.13% 37.04% 58.68% 188.38% 27.05% 105.82% 27.85% -37.99% -39.23% -433.52%
Augmented Payout Ratio
79.46% 80.69% 175.32% 813.81% 27.73% 119.51% 53.04% -96.94% -41.67% -448.14%

Quarterly Metrics and Ratios for Scotts Miracle-Gro

This table displays calculated financial ratios and metrics derived from Scotts Miracle-Gro's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-26.32% -33.11% -6.96% -8.75% -5.68% -24.13% -22.07% -0.40% 7.46% 10.73% 1.56%
EBITDA Growth
-263.31% -1,520.66% -72.41% -45.30% 118.66% -100.97% -92.00% 27.69% 120.08% 49.89% -15.97%
EBIT Growth
-284.90% -519.78% -19.64% -47.31% 113.71% -87.06% -21.64% 31.89% 158.52% 47.74% -6.95%
NOPAT Growth
-271.80% -502.15% -18.08% -50.16% 116.50% -85.76% -13.16% 29.48% 122.35% 48.07% -7.82%
Net Income Growth
-296.50% -359.50% -29.40% -60.43% 109.84% -112.86% -24.42% 43.97% 202.29% 47.92% 13.66%
EPS Growth
-303.30% -365.48% -30.00% -60.73% 109.61% -113.04% -21.37% 41.24% 196.10% 49.46% 14.79%
Operating Cash Flow Growth
-6.05% 15.04% 43.59% 64.16% 21.51% -2.78% 20.48% 324.83% 4.51% -77.86% -29.75%
Free Cash Flow Firm Growth
-770.44% 79.60% 135.64% 219.91% 171.41% 338.00% 47.83% 6.17% 60.52% 6.16% -49.85%
Invested Capital Growth
20.97% -0.67% -13.19% -23.23% -18.29% -21.81% -22.15% -31.13% -34.58% -22.50% -15.02%
Revenue Q/Q Growth
-29.33% -58.38% 6.69% 190.83% -26.95% -66.52% 9.59% 271.69% -21.19% -65.50% 0.51%
EBITDA Q/Q Growth
-228.11% 63.26% 92.35% 1,619.33% -56.30% -495.68% 92.69% 1,110.42% -24.67% -190.10% 83.09%
EBIT Q/Q Growth
-243.87% 60.32% 81.93% 610.95% -62.56% -641.22% 88.25% 653.99% -26.62% -209.41% 75.95%
NOPAT Q/Q Growth
-230.33% 60.18% 81.34% 614.66% -56.86% -548.37% 88.63% 688.87% -25.92% -204.73% 76.40%
Net Income Q/Q Growth
-260.54% 50.42% 70.60% 269.09% -60.05% -1,172.08% 82.82% 295.65% -16.13% -284.71% 71.52%
EPS Q/Q Growth
-262.15% 51.19% 70.08% 265.81% -60.31% -1,181.82% 82.95% 292.96% -16.79% -284.65% 71.26%
Operating Cash Flow Q/Q Growth
222.65% 18.92% -178.39% 68.65% 515.82% -4.85% -164.11% 188.64% 93.29% -79.85% -475.78%
Free Cash Flow Firm Q/Q Growth
-1.60% 86.61% 438.37% 160.40% -39.49% -55.36% 110.17% 87.02% -8.52% -70.48% -0.73%
Invested Capital Q/Q Growth
-20.00% -22.46% 14.84% 7.76% -14.84% -25.81% 14.35% -4.67% -19.11% -12.11% 25.38%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
19.95% -14.34% 18.17% 26.95% 18.41% -15.22% 15.16% 30.40% 29.45% -7.11% 22.74%
EBITDA Margin
-45.00% -39.73% -2.85% 14.88% 8.90% -105.23% -7.02% 19.08% 18.23% -47.62% -8.01%
Operating Margin
-47.42% -45.38% -7.94% 13.46% 6.91% -111.11% -11.53% 17.84% 16.64% -52.11% -12.24%
EBIT Margin
-47.28% -45.08% -7.63% 13.41% 6.87% -111.13% -11.92% 17.76% 16.54% -52.45% -12.55%
Profit (Net Income) Margin
-37.43% -44.59% -12.29% 7.14% 3.91% -125.10% -19.62% 10.33% 10.99% -58.84% -16.67%
Tax Burden Percent
76.97% 81.01% 68.61% 73.03% 84.04% 83.54% 70.49% 71.66% 72.19% 78.16% 72.47%
Interest Burden Percent
102.84% 122.11% 234.58% 72.93% 67.62% 134.74% 233.54% 81.14% 92.05% 143.54% 183.37%
Effective Tax Rate
0.00% 0.00% 0.00% 26.97% 15.96% 0.00% 0.00% 28.34% 27.81% 0.00% 0.00%
Return on Invested Capital (ROIC)
-41.40% -43.78% -6.16% 9.09% 6.41% -109.25% -9.56% 14.78% 17.06% -65.82% -12.99%
ROIC Less NNEP Spread (ROIC-NNEP)
-43.35% -46.58% -7.31% 7.91% 5.71% -116.10% -11.11% 13.54% 16.56% -69.85% -14.21%
Return on Net Nonoperating Assets (RNNOA)
-144.76% -181.86% -50.24% 49.58% 63.00% 5,024.44% 208.72% -721.69% -7,204.46% 487.96% 91.30%
Return on Equity (ROE)
-186.16% -225.64% -56.40% 58.67% 69.41% 4,915.18% 199.16% -706.91% -7,187.39% 422.15% 78.31%
Cash Return on Invested Capital (CROIC)
-24.15% -10.00% 5.33% 15.51% 20.50% 19.66% 20.57% 34.18% 42.05% 32.78% 22.36%
Operating Return on Assets (OROA)
-41.00% -38.89% -6.07% 8.96% 5.34% -102.37% -9.92% 13.67% 14.62% -59.29% -12.97%
Return on Assets (ROA)
-32.45% -38.47% -9.76% 4.77% 3.04% -115.24% -16.33% 7.95% 9.72% -66.51% -17.24%
Return on Common Equity (ROCE)
-186.16% -225.64% -56.40% 58.67% 69.41% 4,915.18% 199.16% -706.91% -7,187.39% 422.15% 78.31%
Return on Equity Simple (ROE_SIMPLE)
-63.45% 0.00% -760.00% -450.40% -97.70% 0.00% 102.72% 138.62% 177.43% 0.00% 4.98%
Net Operating Profit after Tax (NOPAT)
-394 -157 -29 151 65 -291 -33 195 144 -151 -36
NOPAT Margin
-33.20% -31.77% -5.56% 9.83% 5.81% -77.78% -8.07% 12.78% 12.02% -36.48% -8.57%
Net Nonoperating Expense Percent (NNEP)
1.95% 2.79% 1.16% 1.18% 0.70% 6.85% 1.55% 1.24% 0.50% 4.04% 1.22%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - -1.26% - - - -1.61%
Cost of Revenue to Revenue
80.05% 114.34% 81.83% 73.05% 81.59% 115.22% 84.84% 69.60% 70.55% 107.11% 77.26%
SG&A Expenses to Revenue
11.45% 23.99% 24.40% 12.16% 11.49% 28.84% 27.97% 11.72% 12.30% 28.36% 29.94%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
67.37% 31.04% 26.11% 13.48% 11.50% 95.89% 26.68% 12.56% 12.81% 45.00% 34.98%
Earnings before Interest and Taxes (EBIT)
-561 -223 -40 205 77 -416 -49 271 199 -218 -52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-534 -196 -15 228 100 -394 -29 291 219 -198 -33
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.76 14.59 42.47 26.83 24.90 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.98 0.55 0.65 0.99 0.91 0.78 1.00 1.22 1.05 1.37 1.07
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
3.58% 6.79% 5.79% 4.00% 4.41% 5.38% 4.31% 3.57% 4.06% 3.07% 4.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.00 1.71 1.76 2.01 2.08 2.36 2.51 2.83 2.96 4.07 2.98
Enterprise Value to Revenue (EV/Rev)
1.76 1.23 1.47 1.89 1.69 1.48 1.85 2.00 1.65 1.97 1.81
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 53.36 0.00 0.00 0.00 66.41 24.64 23.01
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 316.92 0.00 0.00 0.00 1,260.42 34.40 32.15
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 501.34 0.00 0.00 0.00 941.23 47.85 44.76
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 28.00 15.81 11.37 9.87 10.27 6.47 5.35 10.48 11.37
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 30.64 11.26 9.11 10.55 10.68 6.77 5.57 10.84 12.25
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
8.32 20.11 57.25 25.99 22.85 -9.76 -7.85 -11.23 -17.03 -5.70 -5.61
Long-Term Debt to Equity
7.55 19.13 53.61 22.82 19.50 -9.57 -7.70 -11.00 -16.66 -5.57 -5.50
Financial Leverage
3.34 3.90 6.87 6.27 11.03 -43.28 -18.78 -53.29 -434.93 -6.99 -6.43
Leverage Ratio
6.24 7.84 10.97 10.06 17.09 -64.47 -25.31 -78.59 -696.82 -9.55 -7.96
Compound Leverage Factor
6.42 9.57 25.74 7.34 11.56 -86.87 -59.12 -63.77 -641.44 -13.71 -14.60
Debt to Total Capital
89.27% 95.26% 98.28% 96.29% 95.81% 111.41% 114.61% 109.77% 106.24% 121.27% 121.68%
Short-Term Debt to Total Capital
8.27% 4.63% 6.26% 11.73% 14.02% 2.23% 2.07% 2.25% 2.26% 2.86% 2.47%
Long-Term Debt to Total Capital
81.00% 90.64% 92.03% 84.56% 81.78% 109.18% 112.54% 107.52% 103.98% 118.41% 119.21%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
10.73% 4.74% 1.72% 3.71% 4.19% -11.41% -14.61% -9.77% -6.24% -21.27% -21.68%
Debt to EBITDA
-25.22 -9.23 -10.38 -6.91 26.46 -31.98 -31.69 -87.25 28.51 7.84 9.64
Net Debt to EBITDA
-23.51 -8.36 -9.75 -6.53 24.53 -30.46 -30.63 -82.64 24.08 7.43 9.44
Long-Term Debt to EBITDA
-22.88 -8.78 -9.72 -6.07 22.58 -31.34 -31.12 -85.46 27.91 7.66 9.44
Debt to NOPAT
-20.10 -9.78 -11.05 -8.21 248.55 -21.38 -24.01 -35.32 404.11 15.24 18.75
Net Debt to NOPAT
-18.73 -8.85 -10.38 -7.75 230.48 -20.36 -23.21 -33.45 341.33 14.44 18.36
Long-Term Debt to NOPAT
-18.24 -9.30 -10.35 -7.21 212.17 -20.95 -23.58 -34.59 395.52 14.88 18.37
Altman Z-Score
1.72 1.67 1.81 1.97 1.91 1.51 1.82 2.15 2.27 2.13 2.01
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.42 2.06 2.47 2.07 1.69 1.81 2.20 1.83 1.80 1.31 1.88
Quick Ratio
0.91 0.48 0.55 1.08 0.89 0.43 0.39 0.89 0.92 0.33 0.33
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,028 -138 466 1,213 734 328 689 1,288 1,178 348 345
Operating Cash Flow to CapEx
1,442.37% 0.00% -1,458.11% -609.46% 2,557.27% 2,817.37% -905.54% 1,866.26% 4,454.55% 713.86% -1,519.80%
Free Cash Flow to Firm to Interest Expense
-33.16 -3.93 10.91 25.12 15.59 8.19 16.09 29.21 30.37 10.51 10.25
Operating Cash Flow to Interest Expense
14.94 15.73 -10.11 -2.80 11.94 13.38 -8.02 6.90 15.15 3.58 -13.21
Operating Cash Flow Less CapEx to Interest Expense
13.90 16.86 -10.80 -3.26 11.48 12.91 -8.90 6.53 14.81 3.08 -14.08
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.87 0.86 0.79 0.67 0.78 0.92 0.83 0.77 0.88 1.13 1.03
Accounts Receivable Turnover
4.15 9.10 9.70 2.58 3.48 10.40 8.83 2.94 4.22 14.77 14.20
Inventory Turnover
2.61 2.47 1.91 2.25 2.64 2.60 2.09 2.82 3.61 3.68 2.57
Fixed Asset Turnover
6.90 6.39 6.43 6.18 6.04 5.84 5.71 5.73 5.91 5.83 5.85
Accounts Payable Turnover
8.17 5.91 7.64 6.64 9.22 8.34 8.04 6.44 7.88 10.28 8.34
Days Sales Outstanding (DSO)
88.02 40.10 37.64 141.23 105.03 35.10 41.33 124.26 86.48 24.71 25.70
Days Inventory Outstanding (DIO)
139.61 147.74 191.42 162.13 138.22 140.24 174.98 129.34 101.22 99.13 141.81
Days Payable Outstanding (DPO)
44.70 61.73 47.78 54.98 39.59 43.75 45.40 56.71 46.31 35.52 43.77
Cash Conversion Cycle (CCC)
182.94 126.12 181.28 248.38 203.66 131.58 170.91 196.89 141.40 88.32 123.74
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,660 2,838 3,259 3,512 2,990 2,219 2,537 2,419 1,956 1,719 2,156
Invested Capital Turnover
1.25 1.38 1.11 0.92 1.10 1.40 1.19 1.16 1.42 1.80 1.52
Increase / (Decrease) in Invested Capital
634 -19 -495 -1,063 -669 -619 -722 -1,093 -1,034 -499 -381
Enterprise Value (EV)
7,321 4,846 5,727 7,063 6,212 5,242 6,363 6,856 5,798 6,994 6,426
Market Capitalization
4,079 2,156 2,527 3,689 3,356 2,756 3,441 4,187 3,695 4,884 3,791
Book Value per Share
$7.55 $2.67 $1.07 $2.46 $2.40 ($4.76) ($6.80) ($4.43) ($2.57) ($6.87) ($8.35)
Tangible Book Value per Share
($8.37) ($12.39) ($13.90) ($12.19) ($12.13) ($16.88) ($18.74) ($16.29) ($14.35) ($18.54) ($19.83)
Total Capital
3,896 3,118 3,466 3,711 3,214 2,342 2,638 2,567 2,343 1,836 2,212
Total Debt
3,478 2,971 3,406 3,573 3,080 2,610 3,024 2,818 2,489 2,227 2,692
Total Long-Term Debt
3,156 2,826 3,190 3,138 2,629 2,557 2,969 2,761 2,436 2,174 2,637
Net Debt
3,242 2,690 3,199 3,374 2,856 2,486 2,922 2,669 2,103 2,110 2,635
Capital Expenditures (CapEx)
32 -39 30 22 22 19 38 16 13 17 29
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,811 1,076 1,559 1,880 1,345 645 961 868 457 211 646
Debt-free Net Working Capital (DFNWC)
1,839 1,162 1,584 1,905 1,373 676 972 933 737 283 656
Net Working Capital (NWC)
1,517 1,018 1,368 1,470 922 624 917 875 684 230 602
Net Nonoperating Expense (NNE)
50 63 35 41 21 177 47 37 12 93 34
Net Nonoperating Obligations (NNO)
3,242 2,690 3,199 3,374 2,856 2,486 2,922 2,669 2,103 2,110 2,635
Total Depreciation and Amortization (D&A)
27 26 25 23 23 22 20 20 20 20 19
Debt-free, Cash-free Net Working Capital to Revenue
43.45% 27.41% 40.13% 50.31% 36.65% 18.15% 27.99% 25.30% 13.01% 5.94% 18.16%
Debt-free Net Working Capital to Revenue
44.11% 29.62% 40.79% 50.97% 37.40% 19.05% 28.29% 27.20% 20.98% 7.96% 18.44%
Net Working Capital to Revenue
36.39% 25.94% 35.20% 39.33% 25.12% 17.57% 26.70% 25.51% 19.47% 6.48% 16.90%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($8.01) ($3.95) ($1.17) $1.95 $0.78 ($8.35) ($1.42) $2.77 $2.33 ($4.29) ($1.21)
Adjusted Weighted Average Basic Shares Outstanding
55.40M 55.46M 55.50M 56M 56.20M 56.55M 56.70M 56.80M 56.80M 57.41M 57.30M
Adjusted Diluted Earnings per Share
($8.01) ($3.91) ($1.17) $1.94 $0.77 ($8.33) ($1.42) $2.74 $2.28 ($4.21) ($1.21)
Adjusted Weighted Average Diluted Shares Outstanding
55.40M 55.46M 55.50M 56.50M 56.60M 56.55M 56.70M 57.40M 58M 57.41M 57.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
55.41M 55.46M 55.96M 56.07M 56.16M 56.55M 56.69M 56.80M 56.82M 57.41M 57.47M
Normalized Net Operating Profit after Tax (NOPAT)
67 -134 -23 167 66 -117 -38 196 144 -103 -24
Normalized NOPAT Margin
5.66% -27.12% -4.43% 10.87% 5.93% -31.33% -9.28% 12.88% 11.97% -24.90% -5.79%
Pre Tax Income Margin
-48.62% -55.04% -17.91% 9.78% 4.65% -149.75% -27.83% 14.41% 15.22% -75.28% -23.01%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-18.09 -6.36 -0.94 4.25 1.63 -10.41 -1.14 6.14 5.12 -6.57 -1.55
NOPAT to Interest Expense
-12.70 -4.48 -0.69 3.12 1.38 -7.28 -0.77 4.42 3.72 -4.57 -1.06
EBIT Less CapEx to Interest Expense
-19.13 -5.23 -1.63 3.79 1.17 -10.88 -2.03 5.77 4.78 -7.07 -2.42
NOPAT Less CapEx to Interest Expense
-13.74 -3.35 -1.38 2.66 0.91 -7.76 -1.66 4.05 3.38 -5.07 -1.93
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-56.20% -37.99% -36.64% -23.88% -112.83% -39.23% -37.86% -43.24% -58.13% -433.52% -640.59%
Augmented Payout Ratio
-167.77% -96.94% -65.21% -25.16% -120.05% -41.67% -40.79% -45.49% -60.06% -448.14% -714.23%

Frequently Asked Questions About Scotts Miracle-Gro's Financials

When does Scotts Miracle-Gro's fiscal year end?

According to the most recent income statement we have on file, Scotts Miracle-Gro's financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has Scotts Miracle-Gro's net income changed over the last 9 years?

Scotts Miracle-Gro's net income appears to be on a downward trend, with a most recent value of -$34.90 million in 2024, falling from $158.70 million in 2015. The previous period was -$380.10 million in 2023.

What is Scotts Miracle-Gro's operating income?
Scotts Miracle-Gro's total operating income in 2024 was $208.80 million, based on the following breakdown:
  • Total Gross Profit: $850.50 million
  • Total Operating Expenses: $641.70 million
How has Scotts Miracle-Gro revenue changed over the last 9 years?

Over the last 9 years, Scotts Miracle-Gro's total revenue changed from $2.37 billion in 2015 to $3.55 billion in 2024, a change of 49.8%.

How much debt does Scotts Miracle-Gro have?

Scotts Miracle-Gro's total liabilities were at $3.26 billion at the end of 2024, a 11.4% decrease from 2023, and a 72.2% increase since 2015.

How much cash does Scotts Miracle-Gro have?

In the past 9 years, Scotts Miracle-Gro's cash and equivalents has ranged from $16.60 million in 2020 to $244.10 million in 2021, and is currently $71.60 million as of their latest financial filing in 2024.

How has Scotts Miracle-Gro's book value per share changed over the last 9 years?

Over the last 9 years, Scotts Miracle-Gro's book value per share changed from 10.13 in 2015 to -6.87 in 2024, a change of -167.8%.

Remove Ads


This page (NYSE:SMG) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners